Article

A Highly Sensitive RNA-Based Mutation Detection Approach: Improve the Accuracy and Speed of Liquid Biopsy for Chronic Myeloid Leukemia

2026-08-25

Abstract excerpt

<title>Abstract</title> <p> Background For global molecular diagnostic companies, the occurrence of 1%-10% false positives in detecting single nucleotide variations (SNVs) at the RNA level poses a significant challenge to the application of RNA detection products. In the treatment of chronic myeloid leukemia (CML), highly sensitive and specific rapid detection of <italic>BCR-ABL1</italic> fusion genes and <i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e898823e-1d63-5aec-9ac1-0efa6c921888
DOI: 10.21203/rs.3.rs-9504218/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Highly Sensitive RNA-Based Mutation Detection Approach: Improve the Accuracy and Speed of Liquid Biopsy for Chronic Myeloid LeukemiaDOI 10.21203/rs.3.rs-9504218/v1Read

RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.Semantic proximity Read

Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring.Semantic proximity Read

Analytical Validation of an Automated Semiconductor-Based Next-Generation Sequencing Assay for Detection of DNA and RNA Alterations in Myeloid Neoplasms.Semantic proximity Read

Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patientsSemantic proximity Read

Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase.Semantic proximity Read

Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia PatientsSemantic proximity Read

Advances in next-generation sequencing and emerging technologies for hematologic malignancies.Semantic proximity Read

Technical Validation and Clinical Utility of an NGS Targeted Panel to Improve Molecular Characterization of Pediatric Acute LeukemiaSemantic proximity Read

Performances of targeted RNA-sequencing for the analysis of fusion transcripts, gene mutation and expression in haematological malignanciesSemantic proximity Read

Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnosticsSemantic proximity Read

Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencingSemantic proximity Read

Improving fusion call confidence and reliability through an optimized process in low quality RNA from formalin-fixed, paraffin-embedded samplesSemantic proximity Read